Suven Life Sciences, a leading pharmaceutical company, witnessed a rise in share price on Thursday after it has concluded its Rs 2 billion fund raising exercise through the Qualified Institutions Placement (QIP) process. Anand Rathi Advisors acted as the Sole Global Co-ordinator and Book Running Lead Manager for this QIP.

The transaction saw participation by some highly reputed investors in India. The Company accordingly will issue 1,04,53,690 equity shares of face value of Rs 1 equity share at a price of Rs 191.32 including a premium of Rs 190.32 a share. Post issue the promoters holding will be in excess of 59% as against 64.76% on September 30, 2014.

Shares of the comapny are trading at Rs 223.70, up Rs 3.85, or 1.75% at the Bombay Stock Exchange (BSE) on Thursday at 9:57 a.m.

The scrip has touched an intra-day high of Rs 225.50 and low of Rs 221.75. The total volume of shares traded at the BSE is 81,317.